CN Stock MarketDetailed Quotes

688278 Xiamen Amoytop Biotech

Watchlist

72.72
+1.81+2.55%

Trading Dec 23 14:06 CST

29.58BMarket Cap39.93P/E (TTM)

Xiamen Amoytop Biotech Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Total operating revenue

33.90%1.95B

31.68%1.19B

30.05%545.3M

37.55%2.1B

27.69%1.46B

26.40%903.58M

21.53%419.31M

34.86%1.53B

41.17%1.14B

52.35%714.87M

Operating revenue

33.90%1.95B

31.68%1.19B

30.05%545.3M

37.55%2.1B

27.69%1.46B

26.40%903.58M

21.53%419.31M

34.86%1.53B

41.17%1.14B

52.35%714.87M

Total operating cost

30.42%1.3B

27.57%816.75M

24.66%379.69M

23.30%1.44B

14.73%996.11M

17.68%640.25M

17.61%304.58M

27.66%1.16B

37.93%868.24M

47.16%544.04M

Operating cost

38.79%129.93M

23.73%78.97M

0.09%37.77M

-17.24%140.05M

-23.25%93.62M

-14.77%63.82M

3.11%37.73M

35.25%169.24M

56.10%121.97M

62.07%74.88M

Operating tax surcharges

21.45%9.61M

26.78%6.12M

31.27%2.79M

43.30%11.24M

40.40%7.91M

37.43%4.83M

33.38%2.13M

37.25%7.84M

38.74%5.63M

42.17%3.51M

Operating expense

29.13%777.95M

20.99%499.73M

29.96%241.91M

20.71%848.8M

10.21%602.43M

15.81%413.04M

7.31%186.14M

17.67%703.15M

29.01%546.63M

46.56%356.67M

Administration expense

24.79%190.15M

43.78%119.45M

29.70%54.39M

51.98%210.31M

58.10%152.37M

40.23%83.08M

49.70%41.94M

34.11%138.38M

43.17%96.38M

50.51%59.24M

Financial expense

39.54%-1.86M

17.61%-1.42M

30.08%-750.94K

-15.10%-4.81M

8.94%-3.08M

20.35%-1.73M

-3.25%-1.07M

-282.73%-4.18M

-472.87%-3.38M

-592.79%-2.17M

-Interest expense (Financial expense)

-3.77%357.36K

-8.10%229.42K

-2.77%114.11K

-18.46%506.17K

-25.11%371.36K

-28.61%249.63K

-37.44%117.36K

-42.23%620.73K

48.02%495.87K

--349.65K

-Interest Income (Financial expense)

51.36%-2.33M

42.52%-1.79M

25.64%-975.13K

-45.04%-6.63M

-34.96%-4.79M

-24.37%-3.11M

4.18%-1.31M

-60.22%-4.57M

-93.75%-3.55M

-151.77%-2.5M

Research and development

35.34%193.34M

47.53%113.91M

15.55%43.58M

53.48%229.98M

41.44%142.86M

48.74%77.21M

85.34%37.71M

83.83%149.84M

77.66%101.01M

34.39%51.91M

Credit Impairment Loss

11.81%-547.47K

88.74%-113.8K

135.01%127.38K

-132.95%-463.8K

13.87%-620.78K

-518.11%-1.01M

-1,028.37%-363.79K

-39.22%1.41M

-167.33%-720.71K

-113.54%-163.51K

Asset Impairment Loss

----

---12.76M

----

Other net revenue

Fair value change income

689.64%1.29M

708.65%865.58K

----

566.55%2.65M

-86.27%163.84K

-76.82%107.04K

----

-77.89%397.64K

-76.67%1.19M

-87.58%461.71K

Invest income

1.13%2.28M

-11.91%1.67M

-26.34%1.4M

0.74%3.55M

5.72%2.26M

5.52%1.9M

47.80%1.9M

-29.38%3.52M

2,523.70%2.14M

2,106.53%1.8M

Asset deal income

456.60%45.5K

941.82%44.95K

--44.95K

-90.80%8.84K

-91.49%8.17K

-94.34%4.31K

----

216.07%96.06K

364.21%96.06K

302.42%76.21K

Other revenue

-6.00%14.29M

125.39%9.72M

21.96%3.33M

-40.87%22.98M

-55.84%15.2M

-85.99%4.31M

68.24%2.73M

102.70%38.87M

591.13%34.42M

754.84%30.8M

Operating profit

40.00%672.95M

43.41%385.24M

43.30%170.52M

67.28%680.72M

54.03%480.68M

31.82%268.64M

33.69%118.99M

63.73%406.92M

62.92%312.08M

88.40%203.79M

Add:Non operating Income

129.28%641.07K

119.43%533.53K

188.13%501.72K

47.52%453.06K

182.29%279.61K

241.61%243.14K

310.17%174.13K

85.15%307.12K

-18.93%99.05K

134.88%71.17K

Less:Non operating expense

-16.39%27.84M

-9.20%20.18M

-10.58%13.65M

-21.02%40.52M

-26.15%33.29M

-22.88%22.22M

-7.43%15.26M

53.57%51.31M

68.59%45.08M

72.53%28.82M

Total profit

44.25%645.75M

48.22%365.6M

51.46%157.37M

80.00%640.65M

67.61%447.67M

40.91%246.66M

43.19%103.9M

65.33%355.93M

61.93%267.09M

91.32%175.05M

Less:Income tax cost

16.30%91.6M

37.72%61.26M

44.77%28.56M

23.65%85.21M

18.11%78.77M

7.45%44.48M

30.58%19.73M

102.16%68.91M

79.03%66.69M

113.47%41.39M

Net profit

50.21%554.15M

50.53%304.34M

53.03%128.81M

93.52%555.45M

84.08%368.91M

51.27%202.18M

46.51%84.17M

58.40%287.02M

56.95%200.41M

85.36%133.65M

Net profit from continuing operation

50.21%554.15M

50.53%304.34M

53.03%128.81M

93.52%555.45M

84.08%368.91M

51.27%202.18M

46.51%84.17M

58.40%287.02M

56.95%200.41M

85.36%133.65M

Net profit of parent company owners

50.21%554.15M

50.53%304.34M

53.03%128.81M

93.52%555.45M

84.08%368.91M

51.27%202.18M

46.51%84.17M

58.40%287.02M

56.95%200.41M

85.36%133.65M

Earning per share

Basic earning per share

49.45%1.36

50.00%0.75

52.38%0.32

92.96%1.37

85.71%0.91

51.52%0.5

50.00%0.21

57.78%0.71

58.06%0.49

83.33%0.33

Diluted earning per share

49.45%1.36

50.00%0.75

52.38%0.32

92.96%1.37

85.71%0.91

51.52%0.5

50.00%0.21

57.78%0.71

58.06%0.49

83.33%0.33

Other composite income

Total composite income

50.21%554.15M

50.53%304.34M

53.03%128.81M

93.52%555.45M

84.08%368.91M

51.27%202.18M

46.51%84.17M

58.40%287.02M

56.95%200.41M

85.36%133.65M

Total composite income of parent company owners

50.21%554.15M

50.53%304.34M

53.03%128.81M

93.52%555.45M

84.08%368.91M

51.27%202.18M

46.51%84.17M

58.40%287.02M

56.95%200.41M

85.36%133.65M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Rong Cheng Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Total operating revenue	33.90%1.95B	31.68%1.19B	30.05%545.3M	37.55%2.1B	27.69%1.46B	26.40%903.58M	21.53%419.31M	34.86%1.53B	41.17%1.14B	52.35%714.87M
Operating revenue	33.90%1.95B	31.68%1.19B	30.05%545.3M	37.55%2.1B	27.69%1.46B	26.40%903.58M	21.53%419.31M	34.86%1.53B	41.17%1.14B	52.35%714.87M
Total operating cost	30.42%1.3B	27.57%816.75M	24.66%379.69M	23.30%1.44B	14.73%996.11M	17.68%640.25M	17.61%304.58M	27.66%1.16B	37.93%868.24M	47.16%544.04M
Operating cost	38.79%129.93M	23.73%78.97M	0.09%37.77M	-17.24%140.05M	-23.25%93.62M	-14.77%63.82M	3.11%37.73M	35.25%169.24M	56.10%121.97M	62.07%74.88M
Operating tax surcharges	21.45%9.61M	26.78%6.12M	31.27%2.79M	43.30%11.24M	40.40%7.91M	37.43%4.83M	33.38%2.13M	37.25%7.84M	38.74%5.63M	42.17%3.51M
Operating expense	29.13%777.95M	20.99%499.73M	29.96%241.91M	20.71%848.8M	10.21%602.43M	15.81%413.04M	7.31%186.14M	17.67%703.15M	29.01%546.63M	46.56%356.67M
Administration expense	24.79%190.15M	43.78%119.45M	29.70%54.39M	51.98%210.31M	58.10%152.37M	40.23%83.08M	49.70%41.94M	34.11%138.38M	43.17%96.38M	50.51%59.24M
Financial expense	39.54%-1.86M	17.61%-1.42M	30.08%-750.94K	-15.10%-4.81M	8.94%-3.08M	20.35%-1.73M	-3.25%-1.07M	-282.73%-4.18M	-472.87%-3.38M	-592.79%-2.17M
-Interest expense (Financial expense)	-3.77%357.36K	-8.10%229.42K	-2.77%114.11K	-18.46%506.17K	-25.11%371.36K	-28.61%249.63K	-37.44%117.36K	-42.23%620.73K	48.02%495.87K	--349.65K
-Interest Income (Financial expense)	51.36%-2.33M	42.52%-1.79M	25.64%-975.13K	-45.04%-6.63M	-34.96%-4.79M	-24.37%-3.11M	4.18%-1.31M	-60.22%-4.57M	-93.75%-3.55M	-151.77%-2.5M
Research and development	35.34%193.34M	47.53%113.91M	15.55%43.58M	53.48%229.98M	41.44%142.86M	48.74%77.21M	85.34%37.71M	83.83%149.84M	77.66%101.01M	34.39%51.91M
Credit Impairment Loss	11.81%-547.47K	88.74%-113.8K	135.01%127.38K	-132.95%-463.8K	13.87%-620.78K	-518.11%-1.01M	-1,028.37%-363.79K	-39.22%1.41M	-167.33%-720.71K	-113.54%-163.51K
Asset Impairment Loss	----	----	----	---12.76M	----	----	----	----	----	----
Other net revenue
Fair value change income	689.64%1.29M	708.65%865.58K	----	566.55%2.65M	-86.27%163.84K	-76.82%107.04K	----	-77.89%397.64K	-76.67%1.19M	-87.58%461.71K
Invest income	1.13%2.28M	-11.91%1.67M	-26.34%1.4M	0.74%3.55M	5.72%2.26M	5.52%1.9M	47.80%1.9M	-29.38%3.52M	2,523.70%2.14M	2,106.53%1.8M
Asset deal income	456.60%45.5K	941.82%44.95K	--44.95K	-90.80%8.84K	-91.49%8.17K	-94.34%4.31K	----	216.07%96.06K	364.21%96.06K	302.42%76.21K
Other revenue	-6.00%14.29M	125.39%9.72M	21.96%3.33M	-40.87%22.98M	-55.84%15.2M	-85.99%4.31M	68.24%2.73M	102.70%38.87M	591.13%34.42M	754.84%30.8M
Operating profit	40.00%672.95M	43.41%385.24M	43.30%170.52M	67.28%680.72M	54.03%480.68M	31.82%268.64M	33.69%118.99M	63.73%406.92M	62.92%312.08M	88.40%203.79M
Add:Non operating Income	129.28%641.07K	119.43%533.53K	188.13%501.72K	47.52%453.06K	182.29%279.61K	241.61%243.14K	310.17%174.13K	85.15%307.12K	-18.93%99.05K	134.88%71.17K
Less:Non operating expense	-16.39%27.84M	-9.20%20.18M	-10.58%13.65M	-21.02%40.52M	-26.15%33.29M	-22.88%22.22M	-7.43%15.26M	53.57%51.31M	68.59%45.08M	72.53%28.82M
Total profit	44.25%645.75M	48.22%365.6M	51.46%157.37M	80.00%640.65M	67.61%447.67M	40.91%246.66M	43.19%103.9M	65.33%355.93M	61.93%267.09M	91.32%175.05M
Less:Income tax cost	16.30%91.6M	37.72%61.26M	44.77%28.56M	23.65%85.21M	18.11%78.77M	7.45%44.48M	30.58%19.73M	102.16%68.91M	79.03%66.69M	113.47%41.39M
Net profit	50.21%554.15M	50.53%304.34M	53.03%128.81M	93.52%555.45M	84.08%368.91M	51.27%202.18M	46.51%84.17M	58.40%287.02M	56.95%200.41M	85.36%133.65M
Net profit from continuing operation	50.21%554.15M	50.53%304.34M	53.03%128.81M	93.52%555.45M	84.08%368.91M	51.27%202.18M	46.51%84.17M	58.40%287.02M	56.95%200.41M	85.36%133.65M
Net profit of parent company owners	50.21%554.15M	50.53%304.34M	53.03%128.81M	93.52%555.45M	84.08%368.91M	51.27%202.18M	46.51%84.17M	58.40%287.02M	56.95%200.41M	85.36%133.65M
Earning per share
Basic earning per share	49.45%1.36	50.00%0.75	52.38%0.32	92.96%1.37	85.71%0.91	51.52%0.5	50.00%0.21	57.78%0.71	58.06%0.49	83.33%0.33
Diluted earning per share	49.45%1.36	50.00%0.75	52.38%0.32	92.96%1.37	85.71%0.91	51.52%0.5	50.00%0.21	57.78%0.71	58.06%0.49	83.33%0.33
Other composite income
Total composite income	50.21%554.15M	50.53%304.34M	53.03%128.81M	93.52%555.45M	84.08%368.91M	51.27%202.18M	46.51%84.17M	58.40%287.02M	56.95%200.41M	85.36%133.65M
Total composite income of parent company owners	50.21%554.15M	50.53%304.34M	53.03%128.81M	93.52%555.45M	84.08%368.91M	51.27%202.18M	46.51%84.17M	58.40%287.02M	56.95%200.41M	85.36%133.65M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Rong Cheng Certified Public Accountants (Special General Partnership)	--	--	--	Rong Cheng Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Henan Liliang Diamond